While most cancer cells multiply quickly, some do not, and it’s those “slow proliferators” that may play a key role in a cancer becoming resistant to certain drugs which are designed to kill the fast-growing type. Now, researchers have identified the cause of slowly-dividing cancer cells, paving to way for research into new therapies to target them. Sridhar Ramaswamy, associate professor of medicine at Massachusetts General Hospital Cancer Center, led the study.
Trending News
Research Provides Clues to Spleen’s Role in Coronary Artery Disease
Genetic variants may drive visible changes in the spleen that contribute to heart disease
Patient Who Received Pig Kidney Becomes First To Progress to Human Kidney Transplant
Study shows xenotransplantation can serve as a bridge for patients with end-stage kidney disease
Pilots, Flight Attendants Have Greater Risk of Radiation-Related Cancer Death Than Other Professions
Findings support efforts to protect U.S. aircrews from cosmic radiation exposure